Abstract
Neutrophils are the first cells to be activated in the host immune response to infection or injury and are critical cellular effectors in both humoral and innate immunity, central to the pathogenesis of sepsis and multi-organ dysfunction [1]. However, the neutrophil capacity for bacterial killing lacks selectivity, despite stringent regulation, and thereby carries the potential to inflict collateral damage to, and destruction of host tissue [2]. Host tissue damage characterizes both autoimmune and inflammatory conditions and may arise via a variety of mechanisms including premature neutrophil activation during migration, extracellular release of cytotoxic molecules during microbial killing, removal of infected or damaged host cells or debris during host tissue remodeling, and failure to terminate acute inflammatory responses [3]. Sepsis-induced neutrophil mediated tissue injury has been demonstrated in a variety of organs including the lungs [4, 5], kidneys [6], and liver [7].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Das UN (2000) Critical advances in septicemia and septic shock. Crit Care 4:290–296
Marshall JC (2005) Neutrophils in the pathogenesis of sepsis. Crit Care Med 33:S502–505
Smith JA (1994) Neutrophils, host defense, and inflammation: a double-edged sword. J Leu-koc Biol 56:672–686
Abraham E (2003) Neutrophils and acute lung injury. Crit Care Med 31:S195–199
Moraes TJ, Zurawska JH, Downey GP (2006) Neutrophil granule contents in the pathogenesis of lung injury. Curr Opin Hematol 13:21–27
Heinzelmann M, Mercer-Jones MA, Passmore JC (1999) Neutrophils and renal failure. Am J Kidney Dis 34:384–399
Jaeschke H, Hasegawa T (2006) Role of neutrophils in acute inflammatory liver injury. Liver Int 26:912–919
Kenzel S, Henneke P (2006) The innate immune system and its relevance to neonatal sepsis. Curr Opin Infect Dis 19:264–270
Mizgerd JP (2002) Molecular mechanisms of neutrophil recruitment elicited by bacteria in the lungs. Semin Immunol 14:123–132
Burg ND, Pillinger MH (2001) The neutrophil: function and regulation in innate and humoral immunity. Clin Immunol 99:7–17
Mayadas TN, Cullere X (2005) Neutrophil beta2 integrins: moderators of life or death decisions. Trends Immunol 26:388–395
Halliwell B (2006) Phagocyte-derived reactive species: salvation or suicide? Trends Biochem Sci 31:509–515
Segal AW (2005) How neutrophils kill microbes. Annu Rev Immunol 23:197–223
Marquez LA, Dunford HB (1997) Mechanism of the oxidation of 3,5,3′,5′-tetramethylbenzidine by myeloperoxidase determined by transient-and steady-state kinetics. Biochemistry 36:9349–9355
Arnhold J (2004) Properties, functions, and secretion of human myeloperoxidase. Biochemistry (Mosc) 69:4–9
Furtmuller PG, Arnhold J, Jantschko W, Pichler H, Obinger C (2003) Redox properties of the couples compound I/compound II and compound II/native enzyme of human myeloperoxidase. Biochem Biophys Res Commun 301:551–557
Chapman AL, Hampton MB, Senthilmohan R, Winterbourn CC, Kettle AJ (2002) Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus. J Biol Chem 277:9757–9762
Agner K (1941) Verdoperoxidase. Acta Physiol Scand 2:1–62
IUBMB, Enzyme Nomenclature. EC 1.11.1.7. Available at: http://www.chem.qmul.ac.uk/iubmb/enzyme/ECl/ll/l/7.html. Accessed Dec 2006
Fiedler TJ, Davey CA, Fenna RE (2000) X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution. J Biol Chem 275:1964–11971
Furtmuller PG, Zederbauer M, Jantschko W, et al (2006) Active site structure and catalytic mechanisms of human peroxidases. Arch Biochem Biophys 445:199–213
National Centre for Biotechnology Information. Human Genome Map Viewer. Available at: http://www.ncbi.nlm.nih.gov/mapview/maps.cgi?taxid=9606&CHR=17&maps=genes-r,pheno,morbid,genec&Rl=on&query=MPO&VERBOSE=ON&ZOOM=3 Accessed Dec 2006
Hansson M, Olsson I, Nauseef WM (2006) Biosynthesis, processing, and sorting of human myeloperoxidase. Arch Biochem Biophys 445:214–224
Reynolds WF, Rhees J, Maciejewski D, et al (1999) Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer’s disease. Exp Neurol 155:31–41
Yang JJ, Pendergraft WF, Alcorta DA, et al (2004) Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. J Am Soc Nephrol 15:2103–2114
Petrides PE (1998) Molecular genetics of peroxidase deficiency. J Mol Med 76:688–698
Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF (1996) An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 271:14412–14420
Kumar AP, Piedrafita FJ, Reynolds WF (2004) Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the-463GA promoter polymorphism. J Biol Chem 279:8300–8315
Borregaard N, Theilgaard-Monch K, Sorensen OE, Cowland JB (2001) Regulation of human neutrophil granule protein expression. Curr Opin Hematol 8:23–27
Egesten A, Breton-Gorius J, Guichard J, Gullberg U, Olsson I (1994) The heterogeneity of azu-rophil granules in neutrophil promyelocytes: immunogold localization of myeloperoxidase, cathepsin G, elastase, proteinase 3, and bactericidal/permeability increasing protein. Blood 83:2985–2994
Lamb NJ, Gutteridge JM, Baker C, Evans TW, Quinlan GJ (1999) Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit Care Med 27:1738–1744
Aggarwal A, Baker CS, Evans TW, Haslam PL (2000) G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J 15:895–901
Chollet-Martin S, Jourdain B, Gibert C, Elbim C, Chastre J, Gougerot-Pocidalo MA (1996) Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 154:594–601
Pullar JM, Vissers MC, Winterbourn CC (2000) Living with a killer: the effects of hypochlo-rous acid on mammalian cells. IUBMB Life 50:259–266
Weiss SJ, Lampert MB, Test ST (1983) Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science 222:625–628
Buss IH, Senthilmohan R, Darlow BA, Mogridge N, Kettle AJ, Winterbourn CC (2003) 3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: association with adverse respiratory outcome. Pediatr Res 53:455–462
Spencer JP, Whiteman M, Jenner A, Halliwell B (2000) Nitrite-induced deamination and hypochlorite-induced oxidation of DNA in intact human respiratory tract epithelial cells. Free Radic Biol Med 28:1039–1050
Spickett CM, Jerlich A, Panasenko OM, et al (2000) The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids. Acta Biochim Pol 47:889–899
Vissers MC, Carr AC, Chapman AL (1998) Comparison of human red cell lysis by hypochlorous and hypobromous acids: insights into the mechanism of lysis. Biochem J 330 (Pt 1): 131–138
Winterbourn CC, Kettle AJ (2000) Biomarkers of myeloperoxidase-derived hypochlorous acid. Free Radic Biol Med 29:403–409
Vissers MC, Pullar JM, Hampton MB (1999) Hypochlorous acid causes caspase activation and apoptosis or growth arrest in human endothelial cells. Biochem J 344 Pt 2:443–449
Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K (2003) Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 31:2332–2338
Russell J (2006) Management of sepsis. N Engl J Med 355:1699–1713
Griffin SV, Chapman PT, Lianos EA, Lockwood CM (1999) The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies. Kidney Int 55:917–925
Segelmark M, Persson B, Hellmark T, Wieslander J (1997) Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin? Clin Exp Immunol 108:167–174
Kettle AJ, Winterbourn CC (1994) Superoxide-dependent hydroxylation by myeloperoxidase. J Biol Chem 269:17146–17151
Weiss J (2003) Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria. Biochem Soc Trans 31:785–790
Elsbach P (1998) The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol 64:14–18
Schneider JJ, Unholzer A, Schaller M, Schafer-Korting M, Korting HC (2005) Human defen-sins. J Mol Med 83:587–595
Belaaouaj A, Kim KS, Shapiro SD (2000) Degradation of outer membrane protein A in Esche-richia coli killing by neutrophil elastase. Science 289:1185–1188
Eiserich JP, Baldus S, Brennan ML, et al (2002) Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296:2391–2394
Abu-Soud HM, Hazen SL (2000) Nitric oxide is a physiological substrate for mammalian per-oxidases. J Biol Chem 275:37524–37532
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science + Business Media Inc.
About this paper
Cite this paper
MacCallum, N.S., Quinlan, G.J., Evans, T.W. (2007). The Role of Neutrophil-Derived Myeloperoxidase in Organ Dysfunction and Sepsis. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-49518-7_16
Download citation
DOI: https://doi.org/10.1007/978-0-387-49518-7_16
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-49517-0
Online ISBN: 978-0-387-49518-7
eBook Packages: MedicineMedicine (R0)